Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024
Compare Profit and Loss Results of Indrapr.Medical
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,356.00
1,371.00
-15.00
-1.09%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,356.00
1,371.00
-15.00
-1.09%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
368.00
-368.00
-100.00%
Power & Fuel Cost
27.00
26.00
1.00
3.85%
Employee Cost
277.00
251.00
26.00
10.36%
Operating Expenses
254.00
92.00
162.00
176.09%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
85.00
9.00
76.00
844.44%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
59.00
17.00
42.00
247.06%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,112.00
981.00
131.00
13.35%
Operating Profit (PBDIT) excl Other Income
244.00
389.00
-145.00
-37.28%
Other Income
22.00
22.00
0.00
0.00%
Operating Profit (PBDIT)
266.00
411.00
-145.00
-35.28%
Interest
6.00
36.00
-30.00
-83.33%
Profit before Depriciation and Tax
260.00
375.00
-115.00
-30.67%
Depreciation
44.00
97.00
-53.00
-54.64%
Profit Before Taxation & Exceptional Items
216.00
277.00
-61.00
-22.02%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
216.00
277.00
-61.00
-22.02%
Provision for Tax
55.00
68.00
-13.00
-19.12%
Profit After Tax
160.00
208.00
-48.00
-23.08%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
355.00
833.00
-478.00
-57.38%
Profit Available for appropriations
516.00
1,042.00
-526.00
-50.48%
Appropriations
516.00
1,042.00
-526.00
-50.48%
Equity Dividend (%)
45%
100%
-55.00
Earnings Per Share
17.56
190.95
-173.39
-90.80%
Profit And Loss - Net Sales
Net Sales 1,356.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.97% vs 13.29% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 26.33% vs 28.31% in Mar 2024
Profit And Loss - Interest
Interest 6.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 54.43% vs -5.14% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 160.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.87% vs 43.89% in Mar 2024






